ID: ALA4774281
Type: Binding
Description: Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: U2OS
Target: Interleukin-8 receptor B(ALA2434)
Document: ALA4765436
Antagonist activity at CXCR2 (unknown origin) expressed in U2OS cells cotransfected with beta-arrestin/TEV protease fusion protein and beta-lactamase assessed as inhibition of CXCL8-induced beta arrestin2 recruitment preincubated for 30 mins followed by CXCL8 stimulation and measured after 5 hrs by FRET based fluorescence/Tango assay: 1
Bioactivity
Activity Types for Assay ALA4774281
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
357.17 | 3.24 | 3.24 |
408.52 | 4.72 | 4.72 |
390.53 | 4.88 | 4.88 |
345.49 | 4.10 | 4.10 |
388.56 | 5.39 | 5.39 |
346.48 | 4.70 | 4.70 |
434.58 | 5.19 | 5.19 |
462.64 | 5.97 | 5.97 |
402.54 | 4.49 | 4.49 |
417.60 | 5.24 | 5.24 |
388.56 | 4.85 | 4.85 |
374.53 | 5.17 | 5.17 |
482.57 | 6.27 | 6.27 |
392.52 | 5.31 | 5.31 |
421.59 | 6.25 | 6.25 |
432.61 | 5.96 | 5.96 |
450.58 | 4.60 | 4.60 |
427.53 | 5.02 | 5.02 |
500.73 | 5.70 | 5.70 |
402.59 | 5.95 | 5.95 |
390.53 | 4.88 | 4.88 |
359.52 | 4.36 | 4.36 |
388.56 | 5.56 | 5.56 |
418.58 | 4.82 | 4.82 |
454.52 | 5.50 | 5.50 |
390.53 | 4.59 | 4.59 |
474.69 | 7.13 | 7.13 |
479.67 | 6.07 | 6.07 |
458.53 | 6.07 | 6.07 |
442.53 | 6.19 | 6.19 |
390.53 | 4.84 | 4.84 |
389.55 | 4.76 | 4.76 |
404.56 | 5.18 | 5.18 |
392.52 | 5.31 | 5.31 |
403.57 | 4.50 | 4.50 |
435.62 | 5.93 | 5.93 |
418.58 | 4.82 | 4.82 |
430.64 | 6.47 | 6.47 |
404.56 | 5.15 | 5.15 |
418.58 | 5.36 | 5.36 |
389.55 | 4.16 | 4.16 |
370.50 | 3.81 | 3.81 |
404.56 | 5.18 | 5.18 |
474.53 | 5.48 | 5.48 |
376.51 | 3.96 | 3.96 |
486.58 | 6.85 | 6.85 |
494.68 | 7.74 | 7.74 |